Related Experiment Video
Updated: Jun 13, 2026
09:03
Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
Biocompatible protein nanocontainers for controlled drugs release
Yongsheng Han1, Dmitry Shchukin, Juan Yang
1Interfaces Department, Max Planck Institute of Colloids and Interfaces, D-14424 Potsdam, Germany. yshan@mpikg.mpg.de
ACS Nano
|April 17, 2010
Summary
Researchers developed a novel biocompatible nanocontainer for controlled drug delivery. This protein-based system demonstrates temperature-dependent release and excellent cell compatibility, ideal for hydrophobic medications.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Nanotechnology
Background:
- Controlled release of hydrophobic drugs remains a significant challenge in pharmaceutical development.
- Biocompatible carriers are essential for safe and effective therapeutic delivery.
- Protein-based nanostructures offer promising platforms for drug encapsulation and release.
Purpose of the Study:
- To design and characterize a novel biocompatible nanocontainer for controlled release of hydrophobic drugs.
- To evaluate the drug loading capacity and temperature-dependent release profile of the nanocontainer.
- To assess the in vitro biocompatibility of the developed protein nanocontainers.
Main Methods:
- Protein nanocontainers were fabricated using sonication of oil in a protein aqueous solution.
- Hydrophobic and amphiphilic model drugs (indomethacin and rifampicin) were loaded into the nanocontainers.
- Drug release studies were conducted at varying temperatures (37°C and 40°C).
- Biocompatibility was assessed using 3T3 and B-LCL cell lines.
Main Results:
- High drug loading capacities were achieved: 19 mg/mL for indomethacin and 0.9 mg/mL for rifampicin.
- Drug release exhibited significant temperature dependence, with minimal release at 37°C and complete release at 40°C.
- Protein nanocontainers demonstrated excellent biocompatibility in both 3T3 and B-LCL cell lines.
Conclusions:
- The designed protein nanocontainers are effective carriers for hydrophobic drugs, offering controlled and temperature-responsive release.
- The excellent biocompatibility of these nanocontainers makes them a promising platform for advanced drug delivery applications.
- This system holds potential for developing targeted therapies with enhanced efficacy and reduced side effects.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...